Molecular Mechanisms of Ferroptosis and Their Involvement in Acute Kidney Injury

References

• Susantitaphong P, Cruz DN, Cerda J, et al.; Acute Kidney Injury Advisory Group of the American Society of Nephrology. World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol. 2013;8(9):1482–1493. doi:10.2215/CJN.00710113
   PubMed Web of Science ®Google Scholar
• Chawla LS, Bellomo R, Bihorac A, et al. Acute disease quality initiative workgroup 16. acute kidney disease and renal recovery: consensus report of the acute disease quality initiative (ADQI) 16 workgroup. Nat Rev Nephrol. 2017;13(4):241–257. doi:10.1038/nrneph.2017.2
   PubMed Web of Science ®Google Scholar
• Mehta RL, Cerdá J, Burdmann EA, et al. International society of nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet. 2015;385(9987):2616–2643. doi:10.1016/S0140-6736(15)60126-X
   PubMed Web of Science ®Google Scholar
• Basile DP, Anderson MD, Sutton TA. Pathophysiology of acute kidney injury. Compr Physiol. 2012;2(2):1303–1353.
   PubMed Web of Science ®Google Scholar
• Yang WS, Kim KJ, Gaschler MM, et al. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci U S A. 2016;113(34):E4966–75. doi:10.1073/pnas.1603244113
   PubMed Web of Science ®Google Scholar
• Segura-Aguilar J, Mannervik B. A preclinical model for parkinson’s disease based on transcriptional gene activation via KEAP1/NRF2 to develop new antioxidant therapies. Antioxidants. 2023;12(3):673. doi:10.3390/antiox12030673
   Web of Science ®Google Scholar
• Guo J, Tuo QZ, Lei P. Iron, ferroptosis, and ischemic stroke. J Neurochem. 2023;165:487–520. doi:10.1111/jnc.15807
   PubMed Web of Science ®Google Scholar
• Wan J, Ren H, Wang J. Iron toxicity, lipid peroxidation and ferroptosis after intracerebral haemorrhage. Stroke Vasc Neurol. 2019;4(2):93–95. doi:10.1136/svn-2018-000205
   PubMedGoogle Scholar
• Linkermann A, Skouta R, Himmerkus N, et al. Synchronized renal tubular cell death involves ferroptosis. Proc Natl Acad Sci U S A. 2014;111(47):16836–16841. doi:10.1073/pnas.1415518111
   PubMed Web of Science ®Google Scholar
• Feng Q, Yu X, Qiao Y, et al. Ferroptosis and acute kidney injury (AKI): molecular mechanisms and therapeutic potentials. Front Pharmacol. 2022;13:858676. doi:10.3389/fphar.2022.858676
   PubMed Web of Science ®Google Scholar
• Hu Z, Zhang H, Yang SK, et al. Emerging role of ferroptosis in acute kidney injury. Oxid Med Cell Longev. 2019;2019:8010614. doi:10.1155/2019/8010614
   PubMed Web of Science ®Google Scholar
• Mishima E, Sato E, Ito J, et al. Drugs repurposed as antiferroptosis agents suppress organ damage, including AKI, by functioning as lipid peroxyl radical scavengers. J Am Soc Nephrol. 2020;31(2):280–296. doi:10.1681/ASN.2019060570
   PubMed Web of Science ®Google Scholar
• Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072. doi:10.1016/j.cell.2012.03.042
   PubMed Web of Science ®Google Scholar
• Jiang L, Kon N, Li T. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520(7545):57–62. doi:10.1038/nature14344
   PubMed Web of Science ®Google Scholar
• Angeli JPF, Shah R, Pratt DA, et al. Ferroptosis inhibition: mechanisms and opportunities. Trends Pharmacol Sci. 2017;38(5):489–498. doi:10.1016/j.tips.2017.02.005
   PubMed Web of Science ®Google Scholar
• Chen X, Li J, Kang R, et al. Ferroptosis: machinery and regulation. Autophagy. 2021;17(9):2054–2081. doi:10.1080/15548627.2020.1810918
   PubMed Web of Science ®Google Scholar
• Stockwell BR, Friedmann Angeli JP, Bayir H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171(2):273–285. doi:10.1016/j.cell.2017.09.021
   PubMed Web of Science ®Google Scholar
• Beguin Y, Aapro M, Ludwig H, et al. Epidemiological and nonclinical studies investigating effects of iron in carcinogenesis--a critical review. Crit Rev Oncol Hematol. 2014;89(1):1–15. doi:10.1016/j.critrevonc.2013.10.008
   PubMed Web of Science ®Google Scholar
• Zhi L, Jiao L, Rui K, et al. Lipid metabolism in ferroptosis. Adv Biol. 2021;5:e2100396. doi:10.1002/adbi.202100396
   Google Scholar
• Gao M, Monian P, Quadri N, et al. Glutaminolysis and transferrin regulate ferroptosis. Mol Cell. 2015;59(2):298–308. doi:10.1016/j.molcel.2015.06.011
   PubMed Web of Science ®Google Scholar
• Geng N, Shi BJ, Li SL, et al. Knockdown of ferroportin accelerates erastin-induced ferroptosis in neuroblastoma cells. Eur Rev Med Pharmacol Sci. 2018;22(12):3826–3836. doi:10.26355/eurrev_201806_15267
   PubMed Web of Science ®Google Scholar
• Mancias JD, Wang X, Gygi SP, et al. Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature. 2014;509(7498):105–109. doi:10.1038/nature13148
   PubMed Web of Science ®Google Scholar
• Cabantchik ZI. Labile iron in cells and body fluids: physiology, pathology, and pharmacology. Front Pharmacol. 2014;5:45. doi:10.3389/fphar.2014.00045
   PubMed Web of Science ®Google Scholar
• Ravingerová T, Kindernay L, Barteková M, et al. The molecular mechanisms of iron metabolism and its role in cardiac dysfunction and cardioprotection. Int J Mol Sci. 2020;21(21):7889. doi:10.3390/ijms21217889
   PubMed Web of Science ®Google Scholar
• Anderson GJ, Frazer DM. Current understanding of iron homeostasis. Am J Clin Nutr. 2017;106(Suppl 6):1559S–1566S. doi:10.3945/ajcn.117.155804
   PubMed Web of Science ®Google Scholar
• Dixon SJ, Stockwell BR. The role of iron and reactive oxygen species in cell death. Nat Chem Biol. 2014;10(1):9–17. doi:10.1038/nchembio.1416
   PubMed Web of Science ®Google Scholar
• Leaf DE, Rajapurkar M, Lele SS, et al. Iron, hepcidin, and death in human AKI. J Am Soc Nephrol. 2019;30(3):493–504. doi:10.1681/ASN.2018100979
   PubMed Web of Science ®Google Scholar
• Chen Y, He W, Wei H, et al. Srs11-92, a ferrostatin-1 analog, improves oxidative stress and neuroinflammation via Nrf2 signal following cerebral ischemia/reperfusion injury. CNS Neurosci Ther. 2023;29:1667–1677. doi:10.1111/cns.14130
   PubMedGoogle Scholar
• Dowdle WE, Nyfeler B, Nagel J, et al. Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo. Nat Cell Biol. 2014;16(11):1069–1079. doi:10.1038/ncb3053
   PubMed Web of Science ®Google Scholar
• Hou W, Xie Y, Song X, et al. Autophagy promotes ferroptosis by degradation of ferritin. Autophagy. 2016;12(8):1425–1428. doi:10.1080/15548627.2016.1187366
   PubMed Web of Science ®Google Scholar
• Sato H, Tamba M, Ishii T, et al. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J Biol Chem. 1999;274(17):11455–11458. doi:10.1074/jbc.274.17.11455
   PubMed Web of Science ®Google Scholar
• Conrad M, Friedmann Angeli JP. Glutathione peroxidase 4 (Gpx4) and ferroptosis: what’s so special about it? Molecul Cellular Oncol. 2015;2(3):e995047. doi:10.4161/23723556.2014.995047
   PubMed Web of Science ®Google Scholar
• Zhang Y, Swanda RV, Nie L, et al. mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation. Nat Commun. 2021;12(1):1589. doi:10.1038/s41467-021-21841-w
   PubMed Web of Science ®Google Scholar
• Zhou L, Yu P, Wang -T-T. Wang TTPolydatin attenuates cisplatin-induced acute kidney injury by inhibiting ferroptosis. Oxid Med Cell Longev. 2022;2022:9947191. doi:10.1155/2022/9947191
   PubMed Web of Science ®Google Scholar
• Yu P, Zhang X, Liu N, et al. Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther. 2021;6(1):128. doi:10.1038/s41392-021-00507-5
   PubMed Web of Science ®Google Scholar
• Chen H, Cao L, Han K, et al. Patulin disrupts SLC7A11-cystine-cysteine-GSH antioxidant system and promotes renal cell ferroptosis both in vitro and in vivo. Food Chem Toxicol. 2022;166:113255. doi:10.1016/j.fct.2022.113255
   PubMed Web of Science ®Google Scholar
• Ma L, Zhang X, Yu K, et al. Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. Free Radic Biol Med. 2021;168:25–43. doi:10.1016/j.freeradbiomed.2021.03.023
   PubMed Web of Science ®Google Scholar
• Friedmann Angeli JP, Schneider M, Proneth B, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 2014;16(12):1180–1191. doi:10.1038/ncb3064
   PubMed Web of Science ®Google Scholar
• Yang WS, Stockwell BR. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol. 2008;15(3):234–245. doi:10.1016/j.chembiol.2008.02.010
   PubMedGoogle Scholar
• Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1–2):317–331. doi:10.1016/j.cell.2013.12.010
   PubMed Web of Science ®Google Scholar
• Shui S, Zhao Z, Wang H, et al. Non-enzymatic lipid peroxidation initiated by photodynamic therapy drives a distinct ferroptosis-like cell death pathway. Redox Biol. 2021;45:102056. doi:10.1016/j.redox.2021.102056
   PubMed Web of Science ®Google Scholar
• Zhang J, Bi J, Ren Y, et al. Involvement of GPX4 in irisin’s protection against ischemia reperfusion-induced acute kidney injury. J Cell Physiol. 2021;236(2):931–945. doi:10.1002/jcp.29903
   PubMed Web of Science ®Google Scholar
• Shimada K, Skouta R, Kaplan A, et al. Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis. Nat Chem Biol. 2016;12(7):497–503. doi:10.1038/nchembio.2079
   PubMed Web of Science ®Google Scholar
• Doll S, Proneth B, Tyurina YY, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13(1):91–98. doi:10.1038/nchembio.2239
   PubMed Web of Science ®Google Scholar
• Kagan VE, Mao G, Qu F, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13(1):81–90. doi:10.1038/nchembio.2238
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Yamamoto M. Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Adv Enzyme Regul. 2006;46:113–140. doi:10.1016/j.advenzreg.2006.01.007
   PubMedGoogle Scholar
• Zhang DD, Lo SC, Cross JV, et al. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol Cell Biol. 2004;24(24):10941–10953. doi:10.1128/MCB.24.24.10941-10953.2004
   PubMed Web of Science ®Google Scholar
• Kaspar JW, Niture SK, Jaiswal AK. Nrf2: INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med. 2009;47(9):1304–1309. doi:10.1016/j.freeradbiomed.2009.07.035
   PubMed Web of Science ®Google Scholar
• Kwak MK, Cho JM, Huang B, et al. Role of increased expression of the proteasome in the protective effects of sulforaphane against hydrogen peroxide-mediated cytotoxicity in murine neuroblastoma cells. Free Radic Biol Med. 2007;43(5):809–817. doi:10.1016/j.freeradbiomed.2007.05.029
   PubMed Web of Science ®Google Scholar
• Tonelli C, Chio IIC, Tuveson DA. Transcriptional Regulation by Nrf2. Antioxid Redox Signal. 2018;29(17):1727–1745. doi:10.1089/ars.2017.7342
   PubMed Web of Science ®Google Scholar
• Nezu M, Suzuki N, Yamamoto M. Targeting the KEAP1-NRF2 system to prevent kidney disease progression. Am J Nephrol. 2017;45(6):473–483. doi:10.1159/000475890
   PubMed Web of Science ®Google Scholar
• Doll S, Freitas FP, Shah R, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575(7784):693–698. doi:10.1038/s41586-019-1707-0
   PubMed Web of Science ®Google Scholar
• Bersuker K, Hendricks JM, Li Z, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575(7784):688–692. doi:10.1038/s41586-019-1705-2
   PubMed Web of Science ®Google Scholar
• Lee H, Zandkarimi F, Zhang Y, et al. Energy-stress-mediated AMPK activation inhibits ferroptosis. Nat Cell Biol. 2020;22(2):225–234. doi:10.1038/s41556-020-0461-8
   PubMed Web of Science ®Google Scholar
• Kraft VAN, Bezjian CT, Pfeiffer S, et al. GTP Cyclohydrolase 1/tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent Sci. 2020;6(1):41–53. doi:10.1021/acscentsci.9b01063
   PubMed Web of Science ®Google Scholar
• Li S, Wang R, Wang Y, et al. Ferroptosis: a new insight for treatment of acute kidney injury. Front Pharmacol. 2022;13:1065867. doi:10.3389/fphar.2022.1065867
   PubMed Web of Science ®Google Scholar
• Riegman M, Sagie L, Galed C, et al. Ferroptosis occurs through an osmotic mechanism and propagates independently of cell rupture. Nat Cell Biol. 2020;22(9):1042–1048. doi:10.1038/s41556-020-0565-1
   PubMed Web of Science ®Google Scholar
• Belavgeni A, Maremonti F, Tonnus W, et al. vPIF-1 is an insulin-like antiferroptotic viral peptide. Proc Natl Acad Sci U S A. 2023;120(21):e2300320120. doi:10.1073/pnas.2300320120
   PubMed Web of Science ®Google Scholar
• von Mässenhausen A, Zamora Gonzalez N, Maremonti F, et al. Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor-induced dipeptidase-1 expression and glutathione depletion. Sci Adv. 2022;8(5):eabl8920. doi:10.1126/sciadv.abl8920
   PubMed Web of Science ®Google Scholar
• Carney EF. Ferroptotic stress promotes the AKI to CKD transition. Nat Rev Nephrol. 2021;17(10):633. doi:10.1038/s41581-021-00482-8
   PubMed Web of Science ®Google Scholar
• Sharfuddin AA, Molitoris BA. Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol. 2011;7(4):189–200. doi:10.1038/nrneph.2011.16
   PubMed Web of Science ®Google Scholar
• Jang HR, Rabb H. The innate immune response in ischemic acute kidney injury. Clin Immunol. 2009;130(1):41–50. doi:10.1016/j.clim.2008.08.016
   PubMed Web of Science ®Google Scholar
• Du YW, Li XK, Wang TT, et al. Cyanidin-3-glucoside inhibits ferroptosis in renal tubular cells after ischemia/reperfusion injury via the AMPK pathway. Mol Med. 2023;29(1):42. doi:10.1186/s10020-023-00642-5
   PubMed Web of Science ®Google Scholar
• Tonnus W, Meyer C, Steinebach C, et al. Dysfunction of the key ferroptosis-surveilling systems hypersensitizes mice to tubular necrosis during acute kidney injury. Nat Commun. 2021;12(1):4402. doi:10.1038/s41467-021-24712-6
   PubMed Web of Science ®Google Scholar
• Sun X, Huang N, Li P, et al. TRIM21 ubiquitylates GPX4 and promotes ferroptosis to aggravate ischemia/reperfusion-induced acute kidney injury. Life Sci. 2023;321:121608. doi:10.1016/j.lfs.2023.121608
   PubMed Web of Science ®Google Scholar
• Alim I, Caulfield JT, Chen Y, et al. Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke. Cell. 2019;177(5):1262–1279.e25. doi:10.1016/j.cell.2019.03.032
   PubMed Web of Science ®Google Scholar
• Ioannou MS, Jackson J, Sheu SH, et al. Neuron-astrocyte metabolic coupling protects against activity-induced fatty acid toxicity. Cell. 2019;177(6):1522–1535.e14. doi:10.1016/j.cell.2019.04.001
   PubMed Web of Science ®Google Scholar
• Qi Y, Hu M, Qiu Y, et al. Mitoglitazone ameliorates renal ischemia/reperfusion injury by inhibiting ferroptosis via targeting mitoNEET. Toxicol Appl Pharmacol. 2023;465:116440. doi:10.1016/j.taap.2023.116440
   PubMed Web of Science ®Google Scholar
• Van Coillie S, Van San E, Goetschalckx I, et al. Targeting ferroptosis protects against experimental (multi)organ dysfunction and death. Nat Commun. 2022;13(1):1046. doi:10.1038/s41467-022-28718-6
   PubMed Web of Science ®Google Scholar
• Maremonti F, Locke S, Tonnus W, et al. COVID-19 and diabetic nephropathy. Horm Metab Res. 2022;54(8):510–513. doi:10.1055/a-1819-4822
   PubMedGoogle Scholar
• zDong B, Ding C, Xiang H, et al. USP7 accelerates FMR1-mediated ferroptosis by facilitating TBK1 ubiquitination and DNMT1 deubiquitination after renal ischemia-reperfusion injury. Inflamm Res. 2022;71(12):1519–1533. doi:10.1007/s00011-022-01648-1
   PubMed Web of Science ®Google Scholar
• Pan J, Zhao J, Feng L, Xu X, He Z, Liang W. Inhibition of USP14 suppresses ROS-dependent ferroptosis and alleviates renal ischemia/reperfusion injury. Cell Biochem Biophys. 2023;81(1):87–96. doi:10.1007/s12013-022-01107-y
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang M, Bi R, et al. ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury. Redox Biol. 2022;51:102262. doi:10.1016/j.redox.2022.102262
   PubMed Web of Science ®Google Scholar
• Tao WH, Shan XS, Zhang JX, et al. Dexmedetomidine attenuates ferroptosis-mediated renal ischemia/reperfusion injury and inflammation by inhibiting ACSL4 via α2-AR. Front Pharmacol. 2022;13:782466. doi:10.3389/fphar.2022.782466
   PubMed Web of Science ®Google Scholar
• Yang J, Sun X, Huang N, et al. Entacapone alleviates acute kidney injury by inhibiting ferroptosis. FASEB J. 2022;36(7):e22399. doi:10.1096/fj.202200241RR
   PubMed Web of Science ®Google Scholar
• Zarjou A, Bolisetty S, Joseph R, et al. Proximal tubule H-ferritin mediates iron trafficking in acute kidney injury. J Clin Invest. 2013;123(10):4423–4434. doi:10.1172/JCI67867
   PubMed Web of Science ®Google Scholar
• Zorova LD, Pevzner IB, Chupyrkina AA, et al. The role of myoglobin degradation in nephrotoxicity after rhabdomyolysis. Chem Biol Interact. 2016;256:64–70. doi:10.1016/j.cbi.2016.06.020
   PubMed Web of Science ®Google Scholar
• Zhao S, Wang X, Zheng X, et al. Iron deficiency exacerbates cisplatin- or rhabdomyolysis-induced acute kidney injury through promoting iron-catalyzed oxidative damage. Free Radic Biol Med. 2021;173:81–96. doi:10.1016/j.freeradbiomed.2021.07.025
   PubMed Web of Science ®Google Scholar
• Guo W, Wang Y, Wu Y, et al. Integration of transcriptomics and metabolomics reveals the molecular mechanisms underlying the effect of nafamostat mesylate on rhabdomyolysis-induced acute kidney injury. Front Pharmacol. 2022;13:931670. doi:10.3389/fphar.2022.931670
   PubMed Web of Science ®Google Scholar
• Guo G, Wang Y, Kou W, Gan H. Identifying the molecular mechanisms of sepsis-associated acute kidney injury and predicting potential drugs. Front Genet. 2022;13:1062293. doi:10.3389/fgene.2022.1062293
   PubMed Web of Science ®Google Scholar
• Zhou Z, Zhang H. CHAC1 exacerbates LPS-induced ferroptosis and apoptosis in HK-2 cells by promoting oxidative stress. Allergol Immunopathol. 2023;51(2):99–110. doi:10.15586/aei.v51i2.760
   PubMed Web of Science ®Google Scholar
• Qiu W, An S, Wang T, et al. Melatonin suppresses ferroptosis via activation of the Nrf2/HO-1 signaling pathway in the mouse model of sepsis-induced acute kidney injury. Int Immunopharmacol. 2022;112:109162. doi:10.1016/j.intimp.2022.109162
   PubMed Web of Science ®Google Scholar
• Liu B, Ao S, Tan F, et al. Transcriptomic analysis and laboratory experiments reveal potential critical genes and regulatory mechanisms in sepsis-associated acute kidney injury. Ann Transl Med. 2022;10(13):737. doi:10.21037/atm-22-845
   PubMed Web of Science ®Google Scholar
• Martin-Sanchez D, Ruiz-Andres O, Poveda J, et al. Ferroptosis, but not necroptosis, is important in nephrotoxic folic acid-induced AKI. J Am Soc Nephrol. 2017;28(1):218–229. doi:10.1681/ASN.2015121376
   PubMed Web of Science ®Google Scholar
• Li X, Zou Y, Xing J, et al. Pretreatment with roxadustat (FG-4592) attenuates folic acid-induced kidney injury through antiferroptosis via Akt/GSK-3β/Nrf2 pathway. Oxid Med Cell Longev. 2020;2020:6286984. doi:10.1155/2020/6286984
   PubMed Web of Science ®Google Scholar
• Huang YB, Jiang L, Liu XQ, et al. Melatonin alleviates acute kidney injury by inhibiting NRF2/Slc7a11 axis-mediated ferroptosis. Oxid Med Cell Longev. 2022;2022(83):4776243. doi:10.1155/2022/4776243
   PubMedGoogle Scholar
• Hu M, An S. Ruscogenin prevents folic acid-induced acute kidney damage by inhibiting rev-erbα/β-mediated ferroptosis. Comput Intell Neurosci. 2022;2022:8066126. doi:10.1155/2022/8066126
   PubMed Web of Science ®Google Scholar
• Hu Z, Zhang H, Yi B, et al. VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis. Cell Death Dis. 2020;11(1):73. doi:10.1038/s41419-020-2256-z
   PubMed Web of Science ®Google Scholar
• Zhu Z, Liu X, Li P, et al. Renal clearable quantum dot-drug conjugates modulate labile iron species and scavenge free radicals for attenuating chemotherapeutic drug-induced acute kidney injury. ACS Appl Mater Interfaces. 2023;15(18):21854–21865.
   PubMed Web of Science ®Google Scholar
• Wang S, Zheng Y, Jin S, et al. Dioscin protects against cisplatin-induced acute kidney injury by reducing ferroptosis and apoptosis through activating Nrf2/HO-1 signaling. Antioxidants. 2022;11(12):2443. doi:10.3390/antiox11122443
   Web of Science ®Google Scholar
• Qi H, Deng F, Wang Y, Zhang H, Kanwar YS, Dai Y. Myo-inositol supplementation alleviates cisplatin-induced acute kidney injury via inhibition of ferroptosis. Cells. 2022;12(1):16. doi:10.3390/cells12010016
   PubMed Web of Science ®Google Scholar
• Fan J, Xu X, Li Y, et al. A novel 3-phenylglutaric acid derivative (84-B10) alleviates cisplatin-induced acute kidney injury by inhibiting mitochondrial oxidative stress-mediated ferroptosis. Free Radic Biol Med. 2023;194:84–98. doi:10.1016/j.freeradbiomed.2022.11.029
   PubMed Web of Science ®Google Scholar
• Lin Q, Li S, Jin H, et al. Mitophagy alleviates cisplatin-induced renal tubular epithelial cell ferroptosis through ROS/HO-1/GPX4 axis. Int J Biol Sci. 2023;19(4):1192–1210. doi:10.7150/ijbs.80775
   PubMed Web of Science ®Google Scholar
• Song J, Sheng J, Lei J, et al. Mitochondrial Targeted Antioxidant SKQ1 ameliorates acute kidney injury by inhibiting ferroptosis. Oxid Med Cell Longev. 2022;2022:2223957. doi:10.1155/2022/2223957
   PubMed Web of Science ®Google Scholar